Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Their inability to achieve a R/S and uplisting is directly tied to the company’s inability to execute a liquidity event in a timely manner. They should scrap any intention of uplisting until they do what they said they were going to do last year, which was to complete two liquidity events. If the new strategy does not reconfirm Ken’s commitment to not R/S prior to a $.05 share price, then his credibility is completing gone for me, especially given his comments in Q4 that basically said the liquidity events were nearly done. If you disagree with this comment go listen to the specific comments he made. I will be infuriated if they scrap this part of their strategy, as I am sure others will be who probably bought shares based on Ken’s promise. And yes, this was a promise! Let’s keep our promises Ken.
NOTE: Our uplisting strategy this time last year is no longer relevant. Waiting to see if our stock price will reach $0.05 a share before conducting a R/S (our strategy this time last year) is no longer a feasible strategy, before the 12 month expiration runs out on the 14C information statement filing from May 10th of 2022. With that said, we do not yet know what strategy we will adopt moving forward in the effort to list on NASDAQ, NYSE or any other exchange other than the OTCPINK. When we do know the best strategy and we’re confident in our execution of it, we will announce that strategy through an 8-K filing (and shareholder update.)
The note at the end of your post is certainly on my radar. I get the expiration issue. However, the whole premise of the .05 target Ken put out there was likely based on their assumption of a share price increase following liquidity events, which so far they have failed to deliver on. Any new strategies should include the .05 target before a reverse split. Anything less than this would destroy Ken’s already shaky credibility. All my opinion of course as I have tracked the company’s accomplishments against stated objectives. Time to deliver some liquidity events Ken.
I am thinking Huntpost. Have they posted actuals on their revenues?
Looks like they did $292,775 in Q4 2022. I am thinking based on last year’s growth anything less than $400K in Q1 2023 would be disappointing. That is a conservative 36% growth on a sequential basis from Q4. We shall see. I am going to go out on a limb and predict they do not hit $400K in revenue in Q1 2023. Then the question will be where and when will the vast majority of the $25M in revenue come from. To have any hope of hitting their own forecast they need a good number in Q1.
This is my way of trying to establish some accountability for my assessment of the company’s financial performance. When a company throws out projections they should know where it is coming from and not be just another pie in the sky forecast. They should be very close to forecast.
The problem with the projection is that assuming we are in Year 2 (has this been confirmed), then they woefully missed the Year 1 forecast. Am I wrong in that assessment? If I am correct then how can anyone place and credence in subsequent year projections? It would be illogical to assume Year 2 forecast if they did not come close to Year1.
So what do you forecast Q1 revenue to come in at? I thought I recall Ken mentioning $25M for the year 2024.
No they don’t have any drug vouchers they can sell. They will hopefully land a Priority Review Voucher for rabies once they get some funding and advance the drug in their pipeline.
And it is my opinion they will get their financing. Assuming and hoping they dumped Aegis, with whom they should have never engaged with because they are terrible, they will get a new underwriter is my hunch. They are sitting on some good assets. Someone will take this on. Unfortunately it has taken far longer than anyone expected.
Here is a bio on Gano, Tony’s wife who runs Extreme Realty International along with a video interview she had. This power couple are sting players in the Florida real estate market and Tony is a nationally known trainer.
https://www.xtremeintlrealty.com/9/about_us/167
https://www.globenewswire.com/en/news-release/2022/04/27/2430441/0/en/Decentral-Life-Launches-New-Digital-Wallet-and-Payment-Platform.html
Tony Martinez is affiliated with Extreme Real Estate International. His wife runs the very successful business with nearly 200 agents in Florida. This is the company LikeRE signed up as an early adapter customer for their SaaS business. The dots are connecting here in terms of the relationships. Tony, who also owns the CDPE business, was an advisor for LikeRE and has now been hired as its CEO.
For some reason links are not loading to videos.
If you want to hear from he new LikeRE CEO go to the their website likere.com and look up the video interview there.
That is not the right Tony Martinez Facebook page. If you want to hear the new CEO here is a presentation he gave at a conference. He is currently an advisor on the like RE advisory board.
Not a lie at all. They did the animal studies which concluded with the animal toxicology results under the CRADA. This work was completed by Dr. Emily Chew who is with the NEI. The human trials will also be conducted under the CRADA. If you choose to believe otherwise that is your choice and does not alter the fact they are well into the CRADA. More of a reason for you to sell. I will buy all your shares (I believe you said it was 250K shares) for .013. Just let me know and we can work it out.
They got the CRADA with the NEI which was completed with toxicology results by Dr. Emily Chew, a world renowned eye doctor and researcher. That one fact nullifies your wild and irresponsible claims of fraud and not accomplishing anything they said they were trying to do. Doing what they are trying to do is not an easy proposition. I believe people will be rewarded in time. If you feel they have committed fraud why do you own shares? It seems illogical to me.
Got my orders in. Hopefully they trigger. They are good to cancel so they will need to sell me shares if they want to go low, which I will take. These levels are appealing to me. Last time had a few buys at .017.
That’s a nice position. Hopefully we can get some financing here soon. I am hoping for something private and not a public offering with no reverse split. Would like to see IND before reverse split. Always hated they went with Aegis. We shall see. Funny to me how some people here don’t believe your holdings. LOL. I am not far behind you in share count.
The uplist strategy, whatever that is, will not happen any time soon according to Ken. He pretty much said as much on the call when he said the Nasdaq is not in the near term. Beyond that Ken has stated that they will not reverse split prior to .05. He needs to stay true to his word on that.
On another note, I am glad to see what Huntpost is doing. I think they have big upside. However I go back to the Q4 podcast when he intimated a liquidity event was imminent. Based on yesterday’s podcast it sounds like they are working on LOI’s for 20 trade show companies. There is still a lot of work to do here. Why intimate they were close to a liquidity even in Q4 when it appears now they are still a ways off. I personally am disappointed by the messaging that took place in 2022 and Q4 in particular on the Huntpost liquidity event.
I am still long but always look at things with a critical eye. Still hopeful for positive news moving forward.
This was an email I received from the company 40 minutes ago. Perhaps it is old news. Thought I would send along. Sure it will be discussed on the podcast. Thanks.
MjLink Acquisition Update - February 23rd, 2023
It is official, MjLink has executed a letter of intent to be purchased by a U.S. based company currently operating in the hemp and cannabis industry.
As part of the terms in the LOI, the name of the acquiring cannabis company, and the details of the proposed acquisition, will remain private until the that company makes a public announcement to their shareholders.
In the meantime, both parties are working on the final details that will be added to their Definitive Purchase Agreement.
Please tune in to the shareholder podcast this evening. Use this link to connect and watch...
Should be good valuation. I would like to see the IND drop before the RS and uplist. Maybe with Aegis inability to get the financing done they will secure some short term funding elsewhere. We shall see.
I have a hunch Conix was not being as literal as you are thinking. My interpretation of what he said is that if the stock goes down anywhere near that he’s a buyer. And so am I. In fact, I am a buyer under .02.
Other than the few hundred thousand shares that I have added to my war chest. I’m sure a few other holders here have added at opportune times. And no, I don’t care if you believe me or not. Cheers Rob.
Never ever. Now if they were convicted then that may be a different story. It’s all laughable.
The buy signal has officially appeared. For those here long enough, you know what/who I’m talking about. I’m a buyer on Monday.
A $12.57M market cap here is just ridiculous given the potential of Huntpost alone.
The potential for Huntpost is massive. Been watching a lot of their videos and involvement at the trade show. Love what they are doing. If they can partner with dozens of these trade shows they will become a household name in the outdoor rec. industry. The exposure these mom and pops could get from Huntpost is large. A liquidity event will bring in capital that they could use to really scale their reach. I am most excited about this TBI company.
Just curious why are people limited on their responses?
You obviously know very little about order flow and how Market Makers control it. You should research the topic. What iRobot mentioned has happened to me countless times.
It happens on many stocks. It is market makers controlling order flow. Has happened to me countless times on stocks, not just here. We also don’t see all the orders on Level 2.
It’s called continuing education. Very common for executives to take these types of courses. For some professions it is mandatory. And yes it is completely appropriate to include in a resume. Don’t think he mentioned it to trick anyone. Ive had some criticisms of the company but this entry on a resume is the least of my concerns.
And this may lead to the granting of a PRV which would easily have a $100M value. I have been waiting on progress on other solutions so they are not a one trick pony long term.
They’re an OTC Pink. Come on man. I thought you were leaving.
One question I have is…In a podcast late in 2022 (maybe even December), Ken discussed potential liquidity events for both MJLink and Huntpost. He made it sound like the MJLink acquisition was about to happen and they were literally waiting for documents to be signed by the buyer.
We have heard nothing about this since that call. Makes wonder if that deal has gone south since we have received no update. Again I think Ken should not have positioned it the way he did given the fact that there has been no subsequent update.
I know some may feel like these things take time, there are a lot of moving parts, etc. However, I was left with the feeling it would get done by the end of the year, particularly since Ken had been hinting at liquidity events to happen in 2022 all of last year.
Ken or IR, if you read this, can you please provide an update on this?
Uber the asset is simply a means to an end. Don’t overthink it. It is set up to prequalify companies for their TBI program. Ultimately the company’s success is tied to companies in their TBI program reaching some kind of liquidity event which will allow them to grow their business. WDLF will then own 15% of the company and get 5% of their sales. This is the core of their business strategy. Do this 100 times and you have created a nice incubator company that should create value. The bigger question is not around the value of this asset but rather around when will they actually execute a liquidity event in their TBI program.
Why do you feel they did not do a PR on the original animal studies? They began in early May and should have been completed in mid-August. Seems that would have been a fact-based material, non-promotional event that they could have PR’d to update shareholders. And I think it would have helped the share price. I think they missed an opportunity on this.
When will Ken learn to stop saying things he ends up not doing? This has been a pattern for a long time. He needs to just report news as it happens and stop making promises on communicating that he can’t keep. It is an addiction he needs to break.
I doubt it. Looks like they are pushing it right back to .02 today. If Aegis is involved they will not do retail any favors.
I think they have figured out the formulation.
The animal studies are done. The toxicology test as reported in the PR last week followed the animal studies. They do need to manufacture a small amount of the drug for the human trials that will be administered under the CRADA. This is very typical of the process.
Why don’t you do a little due diligence?